Living With Cervical Cancer: Assessing Utilities Associated With Common Treatment Complications

Cervical Cancer Clinical Trial

Official title:

Living With Cervical Cancer: Assessing Utilities Associated With Common Treatment Complications

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01039493
• Other study ID #: M-2009-1240
• Secondary ID: OS09708
• Status: Completed
• Phase: N/A
• First received: December 23, 2009
• Last updated: September 30, 2015
• Start date: February 2010
• Est. completion date: August 2010

Study information

• Verified date: September 2015
• Source: University of Wisconsin, Madison
• Contact: n/a
• Is FDA regulated: No
• Health authority: United States: Institutional Review Board
• Study type: Observational

Clinical Trial Summary

The objective of this study is to establish patient preferences in regards to common complications of cervical cancer treatments, and to compare these preferences to those of medical providers who care for cervical cancer patients. These preferences will be determined via a interview using the Standard Gamble, which is a well-recognized method for establishing utilities.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 40
• Est. completion date: August 2010
• Est. primary completion date: August 2010
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 18 Years to 61 Years

Eligibility

Inclusion Criteria:

• A subject has to have been diagnosed with early cervical cancer (Stage I or II) within the last 3 years and/or take care of patients with cervical cancer and identify her or himself as one of the following: gynecologic oncologist, radiation oncologist, physician's assistant or nurse.

• Subjects must be =18 and <61 years old.

Exclusion Criteria:

• Subjects who are unable to read and speak English proficiently will be excluded. Proficiency will be assessed by the investigator enrolling patients.

• Subjects who do not have capacity to consent will not be included in this study.

• Subjects may not be investigators on this study.

Study Design

Time Perspective: Cross-Sectional

Related Conditions & MeSH terms

• Cervical Cancer
• Uterine Cervical Neoplasms

Locations

Country	Name	City	State
United States	University of Wisconsin-Madison	Madison	Wisconsin

Sponsors (1)

Lead Sponsor	Collaborator
University of Wisconsin, Madison

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Utilities of complications associated with cervical cancer treatment.		At time of interview	No